Andra AP-fonden’s Alexion Pharmaceuticals ALXN Stock Holding History

Andra AP-fonden’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-119,700	Closed	-$22M	–	617
2021 Q2	$22M	Sell	119,700 -5,500	-4%	-$944K	0.45%	2
2021 Q1	$19.1M	Buy	125,200 +7,200	+6%	+$1.11M	0.42%	5
2020 Q4	$18.4M	Buy	118,000 +48,800	+71%	+$6.27M	0.41%	5
2020 Q3	$7.92M	Buy	69,200 +9,200	+15%	+$993K	0.21%	142
2020 Q2	$6.73M	Buy	60,000 +10,400	+21%	+$1.1M	0.2%	166
2020 Q1	$4.45M	Buy	49,600 +3,900	+9%	+$383K	0.16%	280
2019 Q4	$4.94M	Buy	45,700 +17,800	+64%	+$1.9M	0.14%	385
2019 Q3	$2.73M	Buy	27,900 +5,400	+24%	+$609K	0.08%	563
2019 Q2	$2.95M	Buy	22,500 +4,600	+26%	+$593K	0.08%	567
2019 Q1	$2.42M	Buy	+17,900	New	+$2.23M	0.07%	579
2018 Q3	$2.36M	Buy	17,000 +5,000	+42%	+$627K	0.06%	582
2018 Q2	$1.49M	Sell	12,000 -11,500	-49%	-$1.34M	0.04%	612
2018 Q1	$2.62M	Buy	23,500 +9,300	+65%	+$1.11M	0.07%	591
2017 Q4	$1.7M	Buy	14,200 +5,200	+58%	+$633K	0.04%	594
2017 Q3	$1.26M	Buy	9,000 +1,000	+13%	+$136K	0.03%	618
2017 Q2	$973K	Buy	+8,000	New	+$931K	0.02%	635
2017 Q1	–	Sell	-2,000	Closed	-$245K	–	656
2016 Q4	$245K	Buy	+2,000	New	+$245K	0.01%	643
2016 Q3	–	Sell	-7,100	Closed	-$829K	–	646
2016 Q2	$829K	Buy	7,100 +1,200	+20%	+$170K	0.02%	632
2016 Q1	$821K	Sell	5,900 -700	-11%	-$103K	0.02%	629
2015 Q4	$1.26M	Sell	6,600 -4,800	-42%	-$838K	0.04%	543
2015 Q3	$1.78M	Sell	11,400 -1,000	-8%	-$182K	0.05%	493
2015 Q2	$2.24M	Sell	12,400 -1,100	-8%	-$190K	0.07%	438
2015 Q1	$2.34M	Sell	13,500 -4,000	-23%	-$724K	0.07%	419
2014 Q4	$3.24M	Sell	17,500 -10,500	-38%	-$1.95M	0.08%	375
2014 Q3	$4.64M	Sell	28,000 -7,600	-21%	-$1.25M	0.11%	288
2014 Q2	$5.56M	Sell	35,600 -13,600	-28%	-$2.15M	0.12%	250
2014 Q1	$7.49M	Buy	49,200 +16,900	+52%	+$2.69M	0.17%	190
2013 Q4	$4.3M	Buy	32,300 +19,000	+143%	+$2.28M	0.1%	313
2013 Q3	$1.54M	Buy	13,300 +6,500	+96%	+$713K	0.04%	457
2013 Q2	$627K	Buy	+6,800	New	+$655K	0.02%	523

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return